Aging is the primary risk factor for a wide range of chronic diseases, including neurodegenerative disorders, cardiovascular disease, metabolic dysfunction, cancer, and immune decline. As interest in longevity science and anti-aging therapeutics continues to grow, researchers and drug developers face increasing demand for physiologically relevant preclinical models that accurately recapitulate human aging biology and disease progression and better support translational research and therapeutic development.
In this webinar, we will review the current landscape of aging therapeutics and introduce Biocytogen's portfolio of humanized and knockout (KO) animal models developed to support aging research and anti-aging therapeutic development. This portfolio includes both physiological aging models that mimic natural aging processes and accelerated aging models that rapidly reproduce key aging-associated phenotypes and pathological changes.
Join us to explore how these model systems can support studies of aging mechanisms, disease progression, and therapeutic evaluation, including efficacy and safety assessment, across a wide range of aging research applications.
What you will discover:
Speaker:
Meiqi Zhang, Ph.D.
Product Manager, BioMice Product Department
Panelist:
Qiurong Wang, Ph.D.
Regional Business Development Director
